Biotech advertising for companies with long, technical sales cycles.
Biond runs Google Ads and LinkedIn campaigns for biotech and life science companies, built around how scientific and commercial buyers actually evaluate suppliers and partners.
Why Generic PPC and Paid Search Agencies Underperform in Life Science
Most paid search and PPC agencies are built for B2C or horizontal SaaS, and biotechnology advertising works differently. Scientific buyers, including procurement leads, research directors, BD teams, and CRO or CDMO decision makers, recognise surface level messaging quickly. Niche audiences mean keyword volumes are low, so targeting has to map to real decision makers rather than broad demographic filters. A specialist biotechnology advertising agency reads those signals faster than a generalist managing life science accounts alongside unrelated sectors.
The metric that matters is whether the right people, at the right stage of evaluation, are entering your pipeline.
Biotech advertising services across Google and LinkedIn
Lead generation campaigns built around scientific buyers
Lead generation campaigns built around scientific buyers, designed to reach the right research, commercial, and procurement stakeholders with messaging aligned to how they evaluate and select solutions.
Bridging scientific evaluation with commercial decision-making.
Google Ads
For buyers actively comparing CROs, CDMOs, tools, instruments, and assay platforms.
LinkedIn Ads
Reach defined roles by title, function, company type, and seniority.
Scientific keyword research
Terms tied to assays, services, and commercial intent, not broad categories.
Audience targeting
Filters that isolate real decision makers from a broad professional network.
Ad copy that holds up
Technically and commercially credible, and written to survive hypercritical readers.
Measurement tied to pipeline
Reporting framed around qualified leads and meetings, not impressions.
Landing page alignment
Pages built around the questions a qualified buyer arrives with, so leads don't get lost because of unclear next steps.
Explore web design for life science companiesAdvertising usually works best as one channel within a wider biotech digital marketing programme, so the campaigns connect to the rest of your funnel.
How Biond runs a life science advertising campaign
Audience and keyword research
Map the buyer, the terms they search with, and the filters that isolate them.
Message and ad copy
Copy that reflects the real problem to earn the click.
Landing page alignment
Pages built around what a qualified buyer needs at arrival.
Setup and launch
Architecture that gives the platform enough signal without spreading thin.
Measurement tied to pipeline
Reporting on qualified leads and meetings, not meaningless metrics.
Scientific understanding changes the quality of the campaign
When Biond selects keywords for a CRO campaign, the distinctions between preclinical and clinical studies, GLP compliance, and assay validation are already understood. That fluency tightens targeting and cuts copy iterations, and it makes clear whether underperformance is a targeting, messaging, or landing page problem.
Who this is for
- Biotech, life science and medtech companies building commercial pipeline
- CROs and CDMOs building inbound interest with pharma and biotech sponsors
- Instrument, genomics, and research service companies with niche buyers
- Companies that ran paid campaigns before without generating qualified leads
Founders and commercialisation leads who need campaigns they can defend internally
Talk to Biond about your life science advertising
If your campaigns are not generating qualified conversations, or you are planning a first campaign built on a real understanding of your audience and their evaluation process, a short discovery call is a practical starting point.
Frequently asked questions
Biotech advertising differs from standard B2B advertising because it targets niche scientific audiences, long evaluation cycles, and technically literate buyers who assess messaging carefully. Broad category terms and feature-led copy that perform in general B2B rarely reach qualified life science buyers. Biond builds keyword and audience strategies around specific scientific disciplines, applications, and commercial contexts, with ad copy written the way procurement leads, research directors, and BD teams actually evaluate suppliers and partners.
A life science company should use Google Ads, the main paid search channel, when buyers are actively searching for a specific service or product category, which is common for CROs, CDMOs, and scientific instrument suppliers. LinkedIn Ads suit cases where you need to reach a defined audience by role and organisation, particularly BD and procurement functions not yet in active search. Biond often runs both channels with different objectives, matched to where the buyer sits in the decision process.
Most biotech advertising campaigns need at least two to three months before the pipeline data is reliable enough to draw firm conclusions. Life science B2B sales cycles are long, and niche audiences generate lower click volumes than consumer or horizontal SaaS markets, so meaningful signal accumulates more slowly. Biond sets expectations around this from the start and structures measurement around qualified leads and meetings rather than early impression counts.
Biond runs advertising for the full range of life science companies, and biotech is one sector among several. That includes scientific instrument and genomics companies, CROs, CDMOs, diagnostics companies, and research service providers. Campaigns are built around how each type of scientific and commercial buyer evaluates suppliers, so the targeting and copy reflect that specific market. Biond works with companies in Singapore, Southeast Asia, and Europe, and most advertising engagements can be managed remotely.
Biond can run advertising before positioning and messaging is finalised, though clear positioning makes campaigns far more effective. Ad copy has to say something specific and credible to a defined audience, so if your core value proposition or audience segmentation is not yet defined, Biond usually recommends addressing that first. This can happen through a focused positioning and messaging engagement or as part of a broader biotech marketing strategy workstream before committing budget to paid media.